MLICM
CDLX icon

Metropolitan Life Insurance Company (MetLife)’s Cardlytics CDLX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-124
Closed -$18K – 390
2024
Q1 		$18K Sell
124
-92
-43% -$7.77K ﹤0.01% 1911
2023
Q4 		$19.8K Hold
216
– – ﹤0.01% 1928
2023
Q3 		$35.6K Buy
216
+36
+20% +$4.68K ﹤0.01% 1584
2023
Q2 		$11.4K Buy
+180
New +$10.9K ﹤0.01% 2232
2023
Q1 		– Sell
-203
Closed -$11.7K – 2334
2022
Q4 		$11.7K Sell
203
-1
-0.5% -$62 ﹤0.01% 2234
2022
Q3 		$19.1K Hold
204
– – ﹤0.01% 2050
2022
Q2 		$45.4K Hold
204
– – ﹤0.01% 1566
2022
Q1 		$112K Sell
204
-655
-76% -$396K ﹤0.01% 1124
2021
Q4 		$568K Hold
859
– – 0.01% 1338
2021
Q3 		$721K Buy
859
+12
+1% +$12.2K 0.01% 1191
2021
Q2 		$1.07M Buy
847
+54
+7% +$60.9K 0.02% 957
2021
Q1 		$870K Buy
793
+71
+10% +$93.8K 0.01% 1057
2020
Q4 		$1.03M Sell
722
-73
-9% -$77.9K 0.02% 857
2020
Q3 		$561K Hold
795
– – 0.01% 1141
2020
Q2 		$556K Buy
795
+315
+66% +$182K 0.01% 1128
2020
Q1 		$168K Sell
480
-1
-0.2% -$708 ﹤0.01% 1692
2019
Q4 		$302K Hold
481
– – ﹤0.01% 1634
2019
Q3 		$161K Buy
481
+376
+358% +$121K ﹤0.01% 2023
2019
Q2 		$27.2K Buy
+105
New +$21K ﹤0.01% 2566

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CDLX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 124 shares — an estimated $18K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CDLX in Q2 2019 and held it in 19 quarters. The position peaked at $1.07M in Q2 2021. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 124 Cardlytics shares in Q2 2024, an estimated $18K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cardlytics in Q2 2019 and held it in 19 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cardlytics position peaked at $1.07M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.